This is a permanent results page for your analyzed data. Please save the link in your browser's address bar.
| Title / Description | Expression data from renal cancer xenograft tumor treated with sunitinib or vehicle |
| Accession | GSE66346 |
| Summary | We established 3 types of primary xenograft models (KURC;Kyoto University Renal Cancer-1,2,3) derived from human renal cell carcinoma tissues, and 40 mg/day of sunitinib was orally administered. We performed microarray analysis to compare the gene expression profile of sunitinib-treated primary xenograft tumors (sensitive or resistant status) with that of vehicle-treated. |
| Organism | Homo sapiens |
| Platform | GPL6244 |
| Normalized | False |
| Parsed SOFT file |
| Differential expression method | Characteristic Direction |
| Cutoff | 500 |
| Cell | KURC1 |
| Perturbation | Sunitinib |
| Concentration | 40mg/day |
| Relevant information | Sunitinib resistant (Vehicle Vs. Treatment) |
| Gene lists | Enrichr | L1000CDS2 | PAEA | |
| Up |
|
|||
| Down |
|
|||
| Combined |
|
|
|
